Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy

drug protocol number
MA21573
drug sponsor
Roche
drug study
Tocilzumab
drug trial site
KFSH & RC-J
drug status
Completed
drug phase